Results 31 to 40 of about 931,716 (345)

Treatment for morbid obesity [PDF]

open access: yesPostgraduate Medical Journal, 1999
Summary There is no single unifying theory to explain the aetiology of obesity but several environmental factors, such as decreased physical activity and increased fat intake may contribute to its development in genetically predisposed individuals.
openaire   +2 more sources

Gastrointestinal Symptoms in Morbid Obesity [PDF]

open access: yesFrontiers in Medicine, 2014
Several reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and because there are limited clinic-based studies, we documented the prevalence of upper and lower GI symptoms in morbidly obese individuals in a clinic setting.The
Huseini, Mustafa   +8 more
openaire   +3 more sources

Adherence of Obese Patients from Poland and Germany and Its Impact on the Effectiveness of Morbid Obesity Treatment

open access: yes, 2022
This study aimed to investigate and compare the adherence of patients treated for morbid obesity living in Poland and Germany. Methods: A cross-sectional international multicenter survey design was adopted.
Ratajczak, Piotr   +27 more
core   +1 more source

Trabecular Bone Score and Bone Mineral Density in Postmenopausal Women with Morbid Obesity—A Clinical Paradox

open access: yesMedical Sciences, 2021
Obesity has long been considered to have a protective effect on bone, but specific complications in those with morbid obesity are known to have a detrimental impact on bone architecture.
Antresa Jose   +6 more
doaj   +1 more source

Childhood obesity is associated with shorter leukocyte telomere length [PDF]

open access: yes, 2011
CONTEXT: Obesity in adults is associated with shorter mean leukocyte telomere length (LTL), a marker of biological age that is also associated with age-related conditions including cardiovascular disease and type 2 diabetes. However, studies of childhood
Meyre, D   +17 more
core   +1 more source

Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study

open access: yesBMC Gastroenterology, 2019
Background Irritable bowel syndrome (IBS) is prevalent in patients with morbid obesity. After Roux-en-Y gastric bypass (RYGB) chronic abdominal pain is common, however the etiology is largely unknown. We aimed to study the change in the prevalence of IBS-
Ingvild Kristine Blom-Høgestøl   +7 more
doaj   +1 more source

Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study [PDF]

open access: yesEpidemiology and Health, 2016
OBJECTIVES: The lower mortality rate of obese patients with heart failure (HF) has been partly attributed to reverse causation bias due to weight loss caused by disease.
Maryam Shakiba   +4 more
doaj   +1 more source

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation [PDF]

open access: yes, 2009
Objectives: to assess the clinical effectiveness and cost-effectiveness of bariatric surgery for obesity.Data sources: seventeen electronic databases were searched [MEDLINE; EMBASE; PreMedline In-Process & Other Non-Indexed Citations; The Cochrane ...
Colquitt, JL   +23 more
core   +1 more source

Abdominal pain and symptoms before and after Roux‐en‐Y gastric bypass

open access: yesBJS Open, 2019
Background Despite increased emphasis on patient‐reported outcomes, few studies have focused on abdominal pain symptoms before and after Roux‐en‐Y gastric bypass (RYGB).
M. Chahal‐Kummen   +5 more
doaj   +1 more source

Atherogenic Index of Plasma (AIP) a Tool to Assess Changes in Cardiovascular Disease Risk Post Laparoscopic Sleeve Gastrectomy

open access: yesJournal of Diabetes Research, 2020
Predictive indices like the atherogenic index of plasma (AIP) have been developed to estimate the risk of cardiovascular disease (CVD). Metabolic surgery is the most effective treatment for a rapid improvement of morbid obesity and its comorbidities such
Eman Al Shawaf   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy